Broadly neutralizing antibodies that can recognize multiple strains of HIV may be one component of a combination strategy to achieve long-term HIV remission, experts said at a media briefing on HIV cure research at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention this week in Vancouver.
Estrogen receptors on cells may play a role in HIV latency and reactivation, and drugs targeting these receptors could potentially be used to either promote reactivation of integrated viral genes or keep them silent, according to research presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention and at the preceding IAS Towards an HIV Cure Symposium last month in Vancouver.
IAS 2015: Innovative Linkage to Care Approaches Boost Clinic Visits, HIV Treatment Uptake in African Study
A systematic effort to promote HIV testing, linkage to care for people diagnosed with HIV, and circumcision for those testing negative can result in high levels of diagnosis, linkage to care, and viral suppression in rural communities, a randomized study of combination HIV prevention conducted in South Africa and Uganda has shown. The findings were presented by Ruanne Barnabas of the University of Washington Department of Global Health at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention last month in Vancouver.
Results from the HPTN 067 or ADAPT trial -- a study of Truvada (tenofovir/emtricitabine) pre-exposure prophylaxis for gay men in New York City and Bangkok, and heterosexual women in Cape Town -- add to the growing body of evidence about how best to use PrEP and how its protective effect may vary across population groups and with different dosing schedules, researchers reported at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention last month in Vancouver.